The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Open accessAbstract
BACKGROUND: Evidence on the health effects of total polyunsaturated fatty acids (PUFA) is equivocal. Fish oils are rich in omega-3 PUFA and plant oils in omega-6 PUFA. Evidence suggests that increasing PUFA-rich foods, supplements or supplemented foods can reduce serum cholesterol, but may increase body weight, so overall cardiovascular effects are unclear. OBJECTIVES: To assess effects of increasing total PUFA intake on cardiovascular disease and all-cause mortality, lipids and adiposity in adults. SEARCH METHODS: We searched CENTRAL, MEDLINE and Embase to April 2017 and clinicaltrials.gov and the World Health Organization International Clinical Trials Registry Platform to September 2016, without language restrictions. We checked trials included in relevant systematic reviews. SELECTION CRITERIA: We included randomised controlled trials (RCTs) comparing higher with lower PUFA intakes in adults with or without cardiovascular disease that assessed effects over 12 months or longer. We included full texts, abstracts, trials registry entries and unpublished data. Outcomes were all-cause mortality, cardiovascular disease mortality and events, risk factors (blood lipids, adiposity, blood pressure), and adverse events. We excluded trials where we could not separate effects of PUFA intake from other dietary, lifestyle or medication interventions. DATA COLLECTION AND ANALYSIS: Two review authors independently screened titles and abstracts, assessed trials for inclusion, extracted data, and assessed risk of bias. We wrote to authors of included trials for further data. Meta-analyses used random-effects analysis, sensitivity analyses included fixed-effects and limiting to low summary risk of bias. We assessed GRADE quality of evidence. MAIN RESULTS: We included 49 RCTs randomising 24,272 participants, with duration of one to eight years. Eleven included trials were at low summary risk of bias, 33 recruited participants without cardiovascular disease. Baseline PUFA intake was unclear in most trials, but 3.9% to 8% of total energy intake where reported. Most trials gave supplemental capsules, but eight gave dietary advice, eight gave supplemental foods such as nuts or margarine, and three used a combination of methods to increase PUFA.Increasing PUFA intake probably has little or no effect on all-cause mortality (risk 7.8% vs 7.6%, risk ratio (RR) 0.98, 95% confidence interval (CI) 0.89 to 1.07, 19,290 participants in 24 trials), but probably slightly reduces risk of coronary heart disease events from 14.2% to 12.3% (RR 0.87, 95% CI 0.72 to 1.06, 15 trials, 10,076 participants) and cardiovascular disease events from 14.6% to 13.0% (RR 0.89, 95% CI 0.79 to 1.01, 17,799 participants in 21 trials), all moderate-quality evidence. Increasing PUFA may slightly reduce risk of coronary heart disease death (6.6% to 6.1%, RR 0.91, 95% CI 0.78 to 1.06, 9 trials, 8810 participants) andstroke (1.2% to 1.1%, RR 0.91, 95% CI 0.58 to 1.44, 11 trials, 14,742 participants, though confidence intervals include important harms), but has little or no effect on cardiovascular mortality (RR 1.02, 95% CI 0.82 to 1.26, 16 trials, 15,107 participants) all low-quality evidence. Effects of increasing PUFA on major adverse cardiac and cerebrovascular events and atrial fibrillation are unclear as evidence is of very low quality.Increasing PUFA intake probably slightly decreases triglycerides (by 15%, MD -0.12 mmol/L, 95% CI -0.20 to -0.04, 20 trials, 3905 participants), but has little or no effect on total cholesterol (mean difference (MD) -0.12 mmol/L, 95% CI -0.23 to -0.02, 26 trials, 8072 participants), high-density lipoprotein (HDL) (MD -0.01 mmol/L, 95% CI -0.02 to 0.01, 18 trials, 4674 participants) or low-density lipoprotein (LDL) (MD -0.01 mmol/L, 95% CI -0.09 to 0.06, 15 trials, 3362 participants). Increasing PUFA probably has little or no effect on adiposity (body weight MD 0.76 kg, 95% CI 0.34 to 1.19, 12 trials, 7100 participants).Effects of increasing PUFA on serious adverse events such as pulmonary embolism and bleeding are unclear as the evidence is of very low quality. AUTHORS' CONCLUSIONS: This is the most extensive systematic review of RCTs conducted to date to assess effects of increasing PUFA on cardiovascular disease, mortality, lipids or adiposity. Increasing PUFA intake probably slightly reduces risk of coronary heart disease and cardiovascular disease events, may slightly reduce risk of coronary heart disease mortality and stroke (though not ruling out harms), but has little or no effect on all-cause or cardiovascular disease mortality. The mechanism may be via TG reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1806491 · Cited by 1,008
RetractedLozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070 · cited 2×
“Lozano 2012 Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.”
BackgroundSchulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538 · cited 2×
“Lack of blinding is associated with bias, though smaller levels of bias than lack of allocation concealment (Savovic 2012), especially in trials with objectively measured outcomes (Wood 2008).”
BackgroundComparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966 · cited 3×
“No dietary intake data provided Oslo Diet-Heart 1966 Multifactorial dietary intervention (cannot separate out the effects of PUFAs from other dietary interventions) Oxford Retinopathy 1978 Multifactorial dietary intervention (cannot separate out the effects of PUFAs from other dietary interventions) POUNDS Lost Sacks…”
BackgroundInfluentialBasal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
de Souza, R. J., Mente, A., Maroleanu, A., Cozma, A. I., Ha, V., Kishibe, T., Uleryk, E., Budylowski, P., Schünemann, H., Beyene, J., et al. (2015) · BMJ · doi:10.1136/bmj.h3978 · Cited by 1,424 · cited 2×
“There is evidence that trans fats may be harmful (de Souza 2015), and so may confound our understanding of the PUFA trials.”
BackgroundInfluentialGISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Mozaffarian, D., Micha, R., & Wallace, S. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000252 · Cited by 1,215
Howard, B. V., Van Horn, L., Hsia, J., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · JAMA · doi:10.1001/jama.295.6.655 · Cited by 1,091
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet
Salas-Salvadó, J., Bulló, M., Babio, N., Martínez-González, M. Á., Ibarrola-Jurado, N., Basora, J., Estruch, R., Covas, M. I., Corella, D., Arós, F., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1288 · Cited by 901
Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843
Prentice, R. L., Caan, B., Chlebowski, R. T., Patterson, R., Kuller, L. H., Ockene, J. K., Margolis, K. L., Limacher, M. C., Manson, J. E., Parker, L. M., et al. (2006) · JAMA · doi:10.1001/jama.295.6.629 · Cited by 828
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial
Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., Galvin, J. E., Emond, J., Jack, C. R., Weiner, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1510 · Cited by 764
Hooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthington, H. V., Durrington, P. N., Higgins, J. P. T., Capps, N. E., et al. (2006) · BMJ · doi:10.1136/bmj.38755.366331.2f · Cited by 676
Self-citationCohort Profile: Design and methods of the PREDIMED study
Martinez-Gonzalez, M. A., Corella, D., Salas-Salvado, J., Ros, E., Covas, M. I., Fiol, M., Warnberg, J., Aros, F., Ruiz-Gutierrez, V., Lamuela-Raventos, R. M., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyq250 · Cited by 671
Savović, J., Jones, H., Altman, D., Harris, R., Jűni, P., Pildal, J., Als-Nielsen, B., Balk, E., Gluud, C., Gluud, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16350 · Cited by 668
Prevention of Diabetes With Mediterranean Diets: A Subgroup Analysis of a Randomized Trial
Salas-Salvadó, J., Bulló, M., Estruch, R., Ros, E., Covas, M.-I., Ibarrola-Jurado, N., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1725 · Cited by 650
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607
DAYTON, S., PEARCE, M. L., HASHIMOTO, S., DIXON, W. J., & TOMIYASU, U. (1969) · Circulation · doi:10.1161/01.cir.40.1s2.ii-1 · Cited by 595
Toledo, E., Salas-Salvadó, J., Donat-Vargas, C., Buil-Cosiales, P., Estruch, R., Ros, E., Corella, D., Fitó, M., Hu, F. B., Arós, F., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4838 · Cited by 528
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
The Risk and Prevention Study Collaborative Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205409 · Cited by 510
CONTROLLED TRIAL OF SOYA-BEAN OIL IN MYOCARDIAL INFARCTION
(1968) · The Lancet · doi:10.1016/s0140-6736(68)90746-0 · Cited by 476
Salas-Salvadó, J., Fernández-Ballart, J., Ros, E., Martínez-González, M.-A., Fitó, M., Estruch, R., Corella, D., Fiol, M., Gómez-Gracia, E., Arós, F., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.22.2449 · Cited by 463
Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., & for the SU.FOL.OM3 Collaborative Group (2010) · BMJ · doi:10.1136/bmj.c6273 · Cited by 457
Howard, B. V., Manson, J. E., Stefanick, M. L., Beresford, S. A., Frank, G., Jones, B., Rodabough, R. J., Snetselaar, L., Thomson, C., Tinker, L., et al. (2006) · JAMA · doi:10.1001/jama.295.1.39 · Cited by 426
Chew, E. Y., Clemons, T. E., SanGiovanni, J. P., Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7376 · Cited by 415
Lack of benefit of dietary advice to men with angina: results of a controlled trial
Burr, M. L., Ashfield-Watt, P. A. L., Dunstan, F. D. J., Fehily, A. M., Breay, P., Ashton, T., Zotos, P. C., Haboubi, N. A. A., & Elwood, P. C. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601539 · Cited by 409 · cited 2×
“Only erythrocyte fatty acid ratio reported, no TC or dietary intake data reported DART 2 - Burr 2003 Aimed to increase oily fish intake or update of fish oil capsules.”
BackgroundMediterranean dietary pattern and depression: the PREDIMED randomized trial
Sánchez-Villegas, A., Martínez-González, M. A., Estruch, R., Salas-Salvadó, J., Corella, D., Covas, M. I., Arós, F., Romaguera, D., Gómez-Gracia, E., Lapetra, J., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-208 · Cited by 403
Raitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., et al. (2005) · JAMA · doi:10.1001/jama.293.23.2884 · Cited by 371
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake
Leaf, A., Albert, C. M., Josephson, M., Steinhaus, D., Kluger, J., Kang, J. X., Cox, B., Zhang, H., & Schoenfeld, D. (2005) · Circulation · doi:10.1161/circulationaha.105.549527 · Cited by 364
Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial
Tay, J., Luscombe-Marsh, N. D., Thompson, C. H., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.112581 · Cited by 341
Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316
Dangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., Holder, G. E., Knight, R., Letley, L., Richards, M., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29121 · Cited by 296
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., Summerbell, C. D., Worthington, H. V., Song, F., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub5 · Cited by 295
Self-citationToledo, E., Hu, F. B., Estruch, R., Buil-Cosiales, P., Corella, D., Salas-Salvadó, J., Covas, M. I., Arós, F., Gómez-Gracia, E., Fiol, M., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-207 · Cited by 289
Shinto, L., Quinn, J., Montine, T., Dodge, H. H., Woodward, W., Baldauf-Wagner, S., Waichunas, D., Bumgarner, L., Bourdette, D., Silbert, L., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130722 · Cited by 288
Dodin, S., Lemay, A., Jacques, H., Légaré, F., Forest, J.-C., & Mâsse, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1148 · Cited by 244
Swinburn, B. A., Metcalf, P. A., & Ley, S. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.619 · Cited by 240
Carlisle, J. B. (2017) · Anaesthesia · doi:10.1111/anae.13938 · Cited by 229
Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224
Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.509455 · Cited by 217
de Souza, R. J., Bray, G. A., Carey, V. J., Hall, K. D., LeBoff, M. S., Loria, C. M., Laranjo, N. M., Sacks, F. M., & Smith, S. R. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.026328 · Cited by 192
Chew, E. Y., Clemons, T. E., Agrón, E., Launer, L. J., Grodstein, F., & Bernstein, P. S. (2015) · JAMA · doi:10.1001/jama.2015.9677 · Cited by 191
Bhatt, D. L., Steg, P. G., Brinton, E. A., Jacobson, T. A., Miller, M., Tardif, J., Ketchum, S. B., Doyle, R. T., Murphy, S. A., Soni, P. N., et al. (2017) · Clinical Cardiology · doi:10.1002/clc.22692 · Cited by 183
Effect of a Low-Fat Diet on the Incidence of Actinic Keratosis
Black, H. S., Herd, J. A., Goldberg, L. H., Wolf, J. E., Thornby, J. I., Rosen, T., Bruce, S., Tschen, J. A., Foreyt, J. P., Scott, L. W., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301804 · Cited by 169
Tinker, L. F. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1500 · Cited by 165
Tapsell, L. C., Batterham, M. J., Teuss, G., Tan, S.-Y., Dalton, S., Quick, C. J., Gillen, L. J., & Charlton, K. E. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.19 · Cited by 157
Oral Docosahexaenoic Acid in the Prevention of Exudative Age-Related Macular Degeneration
Souied, E. H., Delcourt, C., Querques, G., Bassols, A., Merle, B., Zourdani, A., Smith, T., & Benlian, P. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.005 · Cited by 157
Dodin, S., Cunnane, S. C., Mâsse, B., Lemay, A., Jacques, H., Asselin, G., Tremblay-Mercier, J., Marc, I., Lamarche, B., Légaré, F., et al. (2008) · Nutrition · doi:10.1016/j.nut.2007.09.003 · Cited by 142
Omega-6 fats for the primary and secondary prevention of cardiovascular disease
Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., Rees, K., Brainard, J. S., Brown, T. J., Ajabnoor, S. M., O'Brien, A. T., Winstanley, L. E., Donaldson, D. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011094.pub4 · Cited by 133
Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year
BLOK, W. L., DESLYPERE, J. ‐., DEMACKER, P. N. M., VAN DER VEN‐JONGEKRIJG, J., HECTORS, M. P. C., VAN DER MEER, J. W. M., & KATAN, M. B. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.2240775.x · Cited by 129
Dietary Prevention of Coronary Heart Disease in Women: The Finnish Mental Hospital Study
MIETTINEN, M., TURPEINEN, O., KARVONEN, M., PEKKARINEN, M., PAAVILAINEN, E., & ELOSUO, R. (1983) · International Journal of Epidemiology · doi:10.1093/ije/12.1.17 · Cited by 127
Oikawa, S., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.029 · Cited by 125
Bemelmans, W. J. E., Lefrandt, J. D., Feskens, E. J. M., Haelst, P. L. V., Broer, J., Meyboom-de Jong, B., May, J. F., Tervaert, J. W. C., & Smit, A. J. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601938 · Cited by 123
Brouwer, I. A., Raitt, M. H., Dullemeijer, C., Kraemer, D. F., Zock, P. L., Morris, C., Katan, M. B., Connor, W. E., Camm, J. A., Schouten, E. G., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp003 · Cited by 120
Álvarez-Pérez, J., Sánchez-Villegas, A., Díaz-Benítez, E. M., Ruano-Rodríguez, C., Corella, D., Martínez-González, M. Á., Estruch, R., Salas-Salvadó, J., Serra-Majem, L., & for the PREDIMED Study Investigators (2016) · Journal of the American College of Nutrition · doi:10.1080/07315724.2015.1102102 · Cited by 116
Ness, A., Hughes, J., Elwood, P., Whitley, E., Smith, G., & Burr, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601342 · Cited by 111
Edel, A. L., Rodriguez-Leyva, D., Maddaford, T. G., Caligiuri, S. P., Austria, J. A., Weighell, W., Guzman, R., Aliani, M., & Pierce, G. N. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.204594 · Cited by 106
Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial
Papadaki, A., Martínez-González, M. Á., Alonso-Gómez, A., Rekondo, J., Salas-Salvadó, J., Corella, D., Ros, E., Fitó, M., Estruch, R., Lapetra, J., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.750 · Cited by 104
Vijayakumar, M., Vasudevan, D. M., Sundaram, K. R., Krishnan, S., Vaidyanathan, K., Nandakumar, S., Chandrasekhar, R., & Mathew, N. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2015.10.384 · Cited by 88
La Rovere, M. T., Pinna, G. D., Maestri, R., Barlera, S., Bernardinangeli, M., Veniani, M., Nicolosi, G. L., Marchioli, R., Tavazzi, L., & for the GISSI-HF Investigators (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs126 · Cited by 82
Advice to eat fish and mood: a randomised controlled trial in men with angina
Ness, A. R., Gallacher, J. E. J., Bennett, P. D., Gunnell, D. J., Rogers, P. J., Kessler, D., & Burr, M. L. (2003) · Nutritional Neuroscience · doi:10.1080/1028415021000056069 · Cited by 50
Unsaturated fats and progression of diabetic retinopathy
Houtsmuller, A. J., Zahn, K. J., & Henkes, H. E. (1980) · Documenta Ophthalmologica · doi:10.1007/bf00141465 · Cited by 44
Favourable Influences of Linoleic Acid on the Progression of Diabetic Micro- and Macroangiopathy
Houtsmuller, A. J., van Hal-Ferwerda, J., Zahn, K. J., & Henkes, H. E. (1980) · Annals of Nutrition and Metabolism · doi:10.1159/000176375 · Cited by 44
Ley, S. J., Metcalf, P. A., Scragg, R. K. R., & Swinburn, B. A. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.09.001 · Cited by 43 · cited 15×
“Published by John Wiley & Sons, Ltd. Ley 2004 (Continued) Incomplete outcome data (attrition bias) All outcomes Unclear risk Unclear, deaths, cancer and CV events are dropouts, trialists asked for data but they were unable to provide any - unclear if any data missing Selective reporting (reporting…”
BackgroundInfluentialDietary Counseling for High Blood Cholesterol in Families at Risk of Coronary Disease
Moy, T. F., Yanek, L. R., Raqueño, J. V., Bezirdjian, P. J., Blumenthal, R. S., Wilder, L. B., & Becker, D. M. (2001) · Preventive Cardiology · doi:10.1111/j.1520-037x.2001.00543.x · Cited by 29
Research works printed but not linked: 461
- Ahn, 2016, Effect of n-3 polyunsaturated fatty acids on regression of coronary atherosclerosis in statin treated patients undergoing percutaneous coronary intervention, Korean Circulation Journal, 46, 481, 10.4070/kcj.2016.46.4.481 · DOI
- Brouwer, 2013, Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the Alpha Omega Trial, PloS One, 8, e81519, 10.1371/journal.pone.0081519 · DOI
- Eussen, 2012, Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction, European Heart Journal, 33, 1582, 10.1093/eurheartj/ehr499 · DOI
- Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: a randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
- Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 8, 278, 10.1016/j.jalz.2011.06.002 · DOI
- Geleijnse, 2010, Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial, American Heart Journal, 159, 539, 10.1016/j.ahj.2009.12.033 · DOI
- Giltay, 2012, No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial, International Journal of Andrology, 35, 680, 10.1111/j.1365-2605.2012.01255.x · DOI
- Giltay, 2011, Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction, American Journal of Clinical Nutrition, 94, 1442, 10.3945/ajcn.111.018259 · DOI
- Hoogeveen, 2012, Effects of n-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega Trial, Nephrology, Dialysis, Transplantation, 27, ii64
- Hoogeveen, 2014, No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial, European Journal of Preventive Cardiology, 21, 1429, 10.1177/2047487313494295 · DOI
- Hoogeveen, 2014, Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial, Clinical Journal of The American Society of Nephrology: CJASN, 9, 1676, 10.2215/CJN.10441013 · DOI
- Kromhout, 2011, N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes, Diabetes Care, 34, 2515, 10.2337/dc11-0896 · DOI
- Bassey, 2000, Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone, British Journal of Nutrition, 83, 629, 10.1017/S0007114500000805 · DOI
- Bassey, 2000, Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone, British Journal of Nutrition, 83, 629, 10.1017/S0007114500000805 · DOI
- Bates, 1977, Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis, British Medical Journal, 2, 932, 10.1136/bmj.2.6092.932-a · DOI
- Dworkin, 1984, Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials, Neurology, 34, 1441, 10.1212/WNL.34.11.1441 · DOI
- Bates, 1978, Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis, British Medical Journal, 2, 1390, 10.1136/bmj.2.6149.1390 · DOI
- Dworkin, 1984, Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials, Neurology, 34, 1441, 10.1212/WNL.34.11.1441 · DOI
- Bates, 1989, A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, 52, 18, 10.1136/jnnp.52.1.18 · DOI · Paper page
- Black, 1995, Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer, International Journal of Cancer, 62, 165, 10.1002/ijc.2910620210 · DOI
- Jaax, 1997, General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer, Nutrition and Cancer, 27, 150, 10.1080/01635589709514517 · DOI
- Brox, 2001, A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects, Lipids, 36, 7, 10.1007/s11745-001-0661-4 · DOI
- Burr, 1989, Fish and the heart, Lancet, ii, 1450
- Burr, 1989, Diet and reinfarction trial (DART): design, recruitment, and compliance, European Heart Journal, 10, 558, 10.1093/oxfordjournals.eurheartj.a059528 · DOI
- Burr, 1992, Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART), European Heart Journal, 13, 166, 10.1093/oxfordjournals.eurheartj.a060141 · DOI
- Burr, 1994, Diet and reinfarction [letter], European Heart Journal, 15, 1152, 10.1093/oxfordjournals.eurheartj.a060645 · DOI
- Fehily, 1989, The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART), Journal of Human Nutrition & Dietetics, 2, 225, 10.1111/j.1365-277X.1989.tb00026.x · DOI
- Tokudome, 2015, Dietary n-3/long-chain n-3 polyunsaturated fatty acids for prevention of sporadic colorectal tumors: a randomized controlled trial in polypectomized participants, Prostaglandins, Leukotrienes, and Essential Fatty Acids, 94, 1, 10.1016/j.plefa.2014.09.001 · DOI
- Tokudome, 2002, Rationale and study design of dietary intervention in patients polypectomized for tumors of the colorectum, Japanese Journal of Clinical Oncology, 32, 550, 10.1093/jjco/hyf108 · DOI
- Doi, 2014, Clinical outcomes of early initiation of pure eicosapentaenoic acid supplement after percutaneous coronary intervention in patients with acute coronary syndrome, European Heart Journal, 35, 1156
- Doi, 2014, Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: a randomized, controlled study, International Journal of Cardiology, 176, 577, 10.1016/j.ijcard.2014.08.055 · DOI
- Nosaka, 2017, Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study, International Journal of Cardiology, 228, 173, 10.1016/j.ijcard.2016.11.105 · DOI · Paper page
- Nosaka, 2016, Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study, Journal of the American College of Cardiology, 67, 573, 10.1016/S0735-1097(16)30574-5 · DOI
- Dullaart, 1992, Long-term effects of linoleic-acid-enriched diet on albuminuria and lipid levels in type 1 (insulin-dependent) diabetic patients with elevated urinary albumin excretion, Diabetologia, 35, 165, 10.1007/BF00402550 · DOI
- Feagan, 2008, Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials, JAMA, 299, 1690, 10.1001/jama.299.14.1690 · DOI · Paper page
- Feagan, 2008, Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials, JAMA, 229, 1690, 10.1001/jama.299.14.1690 · DOI · Paper page
- Danthiir, 2011, The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults, Nutrition Journal, 10, 117, 10.1186/1475-2891-10-117 · DOI
- Danthiir, 2014, Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids, Journal of Nutrition, 144, 311, 10.3945/jn.113.175695 · DOI
- Keen, 1993, Treatment of diabetic neuropathy with gamma-linolenic acid, Diabetes Care, 16, 8, 10.2337/diacare.16.1.8 · DOI · Paper page
- Pasternak, 1996, Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial, Annals of Internal Medicine, 125, 529, 10.7326/0003-4819-125-7-199610010-00001 · DOI
- Sacks, 1994, Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients, Lancet, 344, 1182, 10.1016/S0140-6736(94)90506-1 · DOI · Paper page
- Sacks, 1995, Controlled trial of fish oil for regression of human coronary atherosclerosis, Journal of the American College of Cardiology, 25, 1492, 10.1016/0735-1097(95)00095-L · DOI · Paper page
- Tan, 2010, Dietary Manipulation and Weight Management [thesis]
- Houtsmuller, 1980, Influence of different diets on the progression of diabetic retinopathy, Progress in Food Nutritition and Science, 4, 41
- Kumar, 2012, Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion, Heart Rhythm, 9, 483, 10.1016/j.hrthm.2011.11.034 · DOI
- Kumar, 2013, Effects of long-term omega-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: results from a prospective randomised study, International Journal of Cardiology, 168, 3812, 10.1016/j.ijcard.2013.06.030 · DOI
- Swinburn, 1999, Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins, Journal of the American Dietetic Association, 99, 1400, 10.1016/S0002-8223(99)00339-9 · DOI
- Al-Hilal, 2013, Genetic variation at the FADS1-FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement, Journal of Lipid Research, 54, 542, 10.1194/jlr.P032276 · DOI
- AlSaleh, 2014, Interaction between a CSK gene variant and fish oil intake influences blood pressure in healthy adults, Journal of Nutrition, 144, 267, 10.3945/jn.113.185108 · DOI
- Alsaleh, 2013, Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals, Journal of Nutrition, 143, 1021, 10.3945/jn.112.172585 · DOI
- Hall, 2013, Effect of low doses of long chain n-3 polyunsaturated fatty acids on sleep-time heart rate variability: a randomized, controlled trial, International Journal of Cardiology, 168, 4439, 10.1016/j.ijcard.2013.06.153 · DOI
- Pinto, 2015, Effect of low doses of long chain n-3 PUFA intake on daytime heart rate variability: results from the MARINA study, European Journal of Preventive Cardiology, 1, S146
- Proudman, 2012, Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose, Internal Medicine Journal, 42, 2
- Sanders, 2011, Effect of low doses of long-chain n-3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial, American Journal of Clinical Nutrition, 94, 973, 10.3945/ajcn.111.018036 · DOI
- McIllmurray, 1987, Controlled trial of gamma linolenic acid in Duke's C colorectal cancer, BMJ (Clinical Research Ed.), 294, 1260 (Erratum i, 10.1136/bmj.294.6582.1260 · DOI
- Mendis, 2001, Coconut fat and serum lipoproteins: effects of partial replacement with unsaturated fats, British Journal of Nutrition, 85, 583, 10.1079/BJN2001331 · DOI
- Mita, 2007, Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes, Atherosclerosis, 191, 162, 10.1016/j.atherosclerosis.2006.03.005 · DOI
- Ederer, 1971, Cancer among men on cholesterol lowering diets: experience of five clinical trials, Lancet, 2, 203, 10.1016/S0140-6736(71)90911-1 · DOI
- Heady, 1974, Are PUFA harmful?, British Medical Journal, 1, 115, 10.1136/bmj.1.5898.115-c · DOI
- Baker, 1963, The National Diet-Heart Study: an initial report, JAMA, 185, 105, 10.1001/jama.1963.03060020065024 · DOI
- Brown, 1968, The National Diet Heart Study - implications for dietitians and nutritionists, Journal of the American Dietetic Association, 52, 279, 10.1016/S0002-8223(21)12151-0 · DOI
- Ederer, 1971, Cancer among men on cholesterol-lowering diets: experience from five clinical trials, Lancet, 298, 203, 10.1016/S0140-6736(71)90911-1 · DOI
- Page, 1968, Some observations on the National Diet-Heart Study, Circulation, 37, 313, 10.1161/01.CIR.37.3.313 · DOI
- Baker, 1963, The National Diet-Heart Study: an initial report, JAMA, 185, 105, 10.1001/jama.1963.03060020065024 · DOI
- Brown, 1968, The National Diet Heart Study - implications for dietitians and nutritionists, Journal of the American Dietetic Association, 52, 279, 10.1016/S0002-8223(21)12151-0 · DOI
- Ederer, 1971, Cancer among men on cholesterol-lowering diets: experience from five clinical trials, Lancet, 298, 203, 10.1016/S0140-6736(71)90911-1 · DOI
- Page, 1968, Some observations on the National Diet-Heart Study, Circulation, 37, 313, 10.1161/01.CIR.37.3.313 · DOI
- Nodari, 2011, N-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study, Circulation, 124, 1100, 10.1161/CIRCULATIONAHA.111.022194 · DOI
- Nodari, 2010, Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in heart failure patients, European Heart Journal, 31, 850
- Nodari, 2011, Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy, Journal of the American College of Cardiology, 57, 870, 10.1016/j.jacc.2010.11.017 · DOI · Paper page
- Nodari, 2012, Plasma levels of n-3 polyunsaturated fatty acids and risk of hospitalization in patients with non-ischemic cardiomyopathy, Circulation, 126, 17431
- Ilsey, 1987, Randomised placebo controlled trial of MAXEPA and aspirin/persantin after successful coronary angioplasty, Australian & New Zealand Journal of Medicine, 17, 559
- Nye, 1990, Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty, Australian and New Zealand Journal of Medicine, 20, 549, 10.1111/j.1445-5994.1990.tb01311.x · DOI
- Tatsuno, 2013, Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized long-term (ORL) study, Journal of Clinical Lipidology, 7, 615, 10.1016/j.jacl.2013.09.002 · DOI
- Babio, 2014, Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial, CMAJ Canadian Medical Association Journal, 186, E649, 10.1503/cmaj.140764 · DOI · Paper page
- Barcelo, 2009, Mediterranean-style diet effect on the structural properties of the erythrocyte cell membrane of hypertensive patients: the Prevencion con Dieta Mediterranea Study, Hypertension, 54, 1143, 10.1161/HYPERTENSIONAHA.109.137471 · DOI
- Bullo, 2009, Mediterranean diet and high dietary acid load associated with mixed nuts: effect on bone metabolism in elderly subjects, Journal of the American Geriatrics Society, 57, 1789, 10.1111/j.1532-5415.2009.02481.x · DOI
- Casas, 2014, The effects of the Mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial, PloS One, 9, e100084, 10.1371/journal.pone.0100084 · DOI · Paper page
- Casas, 2013, Inhibition of circulating immune cells related to atherogenesis intervention after 1, 3 and 5 years with Mediterranean diet, Annals of Nutrition and Metabolism, 62, 43
- Cohen, 2013, The association between obesity status and long-term adherence to Mediterranean diet in the PREDIMED trial, Circulation, 127, AP098
- Damasceno, 2013, Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk, Atherosclerosis, 230, 347, 10.1016/j.atherosclerosis.2013.08.014 · DOI · Paper page
- Domenech, 2010, Effect of the Mediterranean diet on blood pressure: the ambulatory blood pressure substudy (Predimed-ABPM), Journal of Hypertension, 28, e373, 10.1097/01.hjh.0000379349.42484.74 · doi:10.1097/01.hjh.0000379349.42484.74
- Domenech, 2014, Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: one-year randomized, clinical trial, Hypertension, 64, 69, 10.1161/HYPERTENSIONAHA.113.03353 · DOI · Paper page
- Razquin, 2009, A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain, European Journal of Clinical Nutrition, 63, 1387, 10.1038/ejcn.2009.106 · DOI · Paper page
- Ruiz-Canela, 2014, Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial, JAMA, 311, 415, 10.1001/jama.2013.280618 · DOI · Paper page
- Sala-Vila, 2014, Changes in ultrasound-assessed carotid intima-media thickness and plaque with a Mediterranean diet: a substudy of the PREDIMED trial, Arteriosclerosis, Thrombosis & Vascular Biology, 34, 439, 10.1161/ATVBAHA.113.302327 · DOI
- Sola, 2011, Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: a randomized, controlled trial, Atherosclerosis, 218, 174, 10.1016/j.atherosclerosis.2011.04.026 · DOI
- Valls-Pedret, 2015, Mediterranean diet and age-related cognitive decline: a randomized clinical trial, JAMA Internal Medicine, 175, 1094, 10.1001/jamainternmed.2015.1668 · DOI · Paper page
- Proudman, 2012, Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose, Internal Medicine Journal, 42, 2
- Proudman, 2015, Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis, British Journal of Nutrition, 114, 885, 10.1017/S0007114515002718 · DOI
- Proudman, 2015, Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use, Annals of the Rheumatic Diseases, 74, 89, 10.1136/annrheumdis-2013-204145 · DOI · Paper page
- ISRCTN79170611 A multicentre, multinational, double blind, randomised, parallel group, placebo-controlled study of ethyl-eicosapentaenoate (EPA) in patients with Huntington's disease (HD) doi.org/10.1186/ISRCTN79170611 · doi:10.1186/isrctn79170611
- Puri, 2005, Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial, Neurology, 65, 286, 10.1212/01.wnl.0000169025.09670.6d · DOI
- Rose, 1965, Corn oil in treatment of ischaemic heart diseases, British Medical Journal, 1, 1531, 10.1136/bmj.1.5449.1531 · DOI · Paper page
- Myrup, 2001, Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy, Scandinavian Journal of Clinical & Laboratory Investigation, 61, 349, 10.1080/003655101316911387 · DOI
- Rossing, 1996, Fish oil in diabetic nephropathy, Diabetes Care, 19, 1214, 10.2337/diacare.19.11.1214 · DOI
- Djuric, 1991, Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells, Journal of the National Cancer Institute, 83, 766, 10.1093/jnci/83.11.766 · DOI · Paper page
- Djuric, 1994, Dietary modulation of oxidative DNA damage, Advances In Experimental Medicine and Biology, 354, 71, 10.1007/978-1-4899-0939-8_5 · DOI
- Kasim, 1993, Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women, American Journal of Clinical Nutrition, 57, 146, 10.1093/ajcn/57.2.146 · DOI
- Simon, 1997, A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer, Nutrition and Cancer, 27, 136, 10.1080/01635589709514515 · DOI
- Blacket, 1979, The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease, Australian and New Zealand Journal of Medicine, 9, 521, 10.1111/j.1445-5994.1979.tb03388.x · DOI
- Ramsden, 2013, Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis, BMJ, 346, e8707 (Erratum, 10.1136/bmj.e8707 · DOI · Paper page
- Woodhill, 1978, Low fat, low cholesterol diet in secondary prevention of coronary heart disease, Advances in Experimental Medicine and Biology, 109, 317, 10.1007/978-1-4684-0967-3_18 · DOI · Paper page
- Dayton, 1966, Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat, Journal of Lipid Research, 7, 103, 10.1016/S0022-2275(20)39591-2 · DOI · Paper page
- Dayton, 1967, Adipose tissue linoleic acid as a criterion of adherence to a modified diet, Journal of Lipid Research, 8, 508, 10.1016/S0022-2275(20)38909-4 · DOI
- Dayton, 1965, Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man, Circulation, 32, 911, 10.1161/01.CIR.32.6.911 · DOI
- Dayton, 1965, Vitamin E status of humans during prolonged feeding of unsaturated fats, Journal of Laboratory and Clinical Medicine, 65, 739
- Dayton, 1970, Diet and atherosclerosis, Lancet, 1, 473, 10.1016/S0140-6736(70)90868-8 · DOI
- Dayton, 1969, Diet and cardiovascular diseases, Lancet, 1, 51, 10.1016/S0140-6736(69)91010-1 · DOI
- Dayton, 1969, Diet high in unsaturated fat: a controlled clinical trial, Minnesota Medicine, 1969, 1237
- Dayton, 1969, Prevention of coronary heart disease and other complications of atherosclerosis by modified diet, American Journal of Medicine, 46, 751, 10.1016/0002-9343(69)90026-6 · DOI
- Dayton, 1968, Trial of unsaturated-fat diet, Lancet, 2, 1296, 10.1016/S0140-6736(68)91783-2 · DOI
- Dayton, 1968, Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications, Lancet, 2, 1060, 10.1016/S0140-6736(68)91531-6 · DOI · Paper page
- Dayton, 1962, A controlled clinical trial of a diet high in unsaturated fat, New England Journal of Medicine, 266, 1017, 10.1056/NEJM196205172662001 · DOI · Paper page
- Ederer, 1971, Cancer among men on cholesterol-lowering diets: experience from five clinical trials, Lancet, 298, 203, 10.1016/S0140-6736(71)90911-1 · DOI
- Hiscock, 1962, A palatable diet high in unsaturated fat, Journal of the American Dietetic Association, 40, 427, 10.1016/S0002-8223(21)15876-6 · DOI
- Pearce, 1971, Incidence of cancer in men on a diet high in polyunsaturated fat, Lancet, 1, 464, 10.1016/S0140-6736(71)91086-5 · DOI · Paper page
- Sturdevant, 1973, Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet, New England Journal of Medicine, 288, 24, 10.1056/NEJM197301042880106 · DOI · Paper page
- Tompkins, 1964, Effect of long-term feeding of various fats on whole blood clotting times in men, Journal of Laboratory and Clinical Medicine, 64, 763
- Nandakumar, 2014, Coconut oil vs sunflower oil in atherosclerosis: challenges in dietary intervention, Indian Heart Journal, 66, S11, 10.1016/j.ihj.2014.10.030 · DOI
- Vijayakumar, 2014, What oil in patients with established coronary artery disease: outcomes of two year dietary intervention with coconut oil & sunflower oil, Indian Heart Journal, 66, S12, 10.1016/j.ihj.2014.10.033 · DOI
- Bitok, 2017, Favourable nutrient intake and displacement with long-term walnut supplementation among elderly: results of a randomised trial, British Journal of Nutrition, 118, 201, 10.1017/S0007114517001957 · DOI
- Bitok, 2016, Does a daily walnut supplement given for a year result in body weight gain?, FASEB Journal, 30, 1157
- Huey L Bitok E Kazzi N Sirirat R Haddad Tabrizi S Ros E Dietary compliance of walnut or no walnut intake in a 1-year randomized intervention trial among free-living elderly in the Walnuts and Healthy Aging Study (WAHA) FASEB Journal 2016 1157.10 · DOI
- Rajaram, 2016, The Walnuts and Healthy Aging Study (WAHA): protocol for a nutritional intervention trial with walnuts on brain aging, Frontiers in Aging Neuroscience, 8, 333
- Ros, 2016, Effect of a 1-year walnut supplementation on blood lipids among older individuals: findings from the walnuts and healthy aging (WAHA) study, FASEB Journal, 30, 293
- Bhatia, 2016, Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression, Atherosclerosis, 246, 13, 10.1016/j.atherosclerosis.2015.12.028 · DOI
- Byrne, 2014, Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1155, 10.1161/ATVBAHA.114.303034 · DOI · Paper page
- Byrne CD Targher G Time to replace assessment of liver histology with MR-based imaging tests to assess efficacy of interventions for nonalcoholic fatty liver disease Gastroenterology 2016 7 10 · DOI
- Clough, 2016, Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial, Diabetologia, 59, 1422, 10.1007/s00125-016-3966-8 · DOI
- McCormick, 2015, Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial, Diabetologia, 58, 1916, 10.1007/s00125-015-3628-2 · DOI
- Scorletti, 2014, Design and rationale of the WELCOME trial: a randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease, Contemporary Clinical Trials, 37, 301-11 (Erratum, 10.1016/j.cct.2014.02.002 · DOI
- Scorletti, 2015, Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial, Journal of Hepatology, 63, 1476, 10.1016/j.jhep.2015.07.036 · DOI
- Targher, 2013, Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications, Journal of Clinical Endocrinology and Metabolism, 98, 483, 10.1210/jc.2012-3093 · DOI · Paper page
- Chlebowski, 1993, Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study, Journal of Clinical Oncology, 11, 2072, 10.1200/JCO.1993.11.11.2072 · DOI
- Chlebowski, 2006, Dietary fat reduction and breast cancer outcome: interim efficacy results from the women's intervention nutrition study, JNCI Journal of the National Cancer Institute, 98, 1767, 10.1093/jnci/djj494 · DOI · Paper page
- Chlebowski, 1990, Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues, Adjuvant. The Cancer Journal, 6, 357
- Hoy, 2009, Implementing a low-fat eating plan in the Women's Intervention Nutrition Study, Journal of the American Dietetic Association, 109, 688, 10.1016/j.jada.2008.12.016 · DOI
- Rose, 1992, Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients, Cancer Research, 52, 5386
- Rose, 1993, The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients, Breast Cancer Research & Treatment, 27, 253, 10.1007/BF00665695 · DOI
- Wynder, 1997, The challenges of assessing fat intake in cancer research investigations, Journal of the American Dietetic Association, 97, S5, 10.1016/S0002-8223(97)00723-2 · DOI
- Nigam, 2014, Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress, Journal of the American College of Cardiology, 64, 1441, 10.1016/j.jacc.2014.07.956 · DOI
- Nigam, 2013, Multicentre trial of fish oil for the reduction of atrial fibrillation recurrence, inflammation and oxidative stress: the Atrial Fibrillation Fish Oil Research Study, Canadian Journal of Cardiology, 1, S383, 10.1016/j.cjca.2013.07.658 · DOI
- Brouwer, 2013, Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial, PLoS One, 8, e81519, 10.1371/journal.pone.0081519 · DOI
- Eussen, 2012, Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction, European Heart Journal, 33, 1582, 10.1093/eurheartj/ehr499 · DOI
- Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: a randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
- Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 8, 278, 10.1016/j.jalz.2011.06.002 · DOI
- Geleijnse, 2010, Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial, American Heart Journal, 159, 539, 10.1016/j.ahj.2009.12.033 · DOI
- Giltay, 2012, No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial, International Journal of Andrology, 35, 680, 10.1111/j.1365-2605.2012.01255.x · DOI
- Giltay, 2011, Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction, American Journal of Clinical Nutrition, 94, 1442, 10.3945/ajcn.111.018259 · DOI
- Hoogeveen, 2012, Effects of n-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega trial, Nephrology Dialysis Transplantation, 27, ii64
- Hoogeveen, 2014, No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega trial, European Journal of Preventive Cardiology, 21, 1429, 10.1177/2047487313494295 · DOI
- Hoogeveen, 2014, Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega trial, Clinical Journal of The American Society of Nephrology: CJASN, 9, 1676, 10.2215/CJN.10441013 · DOI
- Kromhout, 2011, N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes, Diabetes Care, 34, 2515, 10.2337/dc11-0896 · DOI
- Kromhout, 2010, N-3 fatty acids and cardiovascular events after myocardial infarction, New England Journal of Medicine, 363, 2015, 10.1056/NEJMoa1003603 · DOI · Paper page
- Bonds, 2014, Effect of long-chain omega-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial, JAMA Internal Medicine, 174, 763, 10.1001/jamainternmed.2014.328 · DOI · Paper page
- Chew, 2012, The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1), Ophthalmology, 119, 2282, 10.1016/j.ophtha.2012.05.027 · DOI · Paper page
- Chew, 2014, In reply: making sense of the evidence from the age-related eye disease study 2 randomized clinical trial, JAMA Ophthalmology, 132, 1031, 10.1001/jamaophthalmol.2014.2009 · DOI
- Chew, 2013, Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4, JAMA Ophthalmology, 131, 843, 10.1001/jamaophthalmol.2013.4412 · DOI
- Huynh, 2014, Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5, Ophthalmology, 121, 1229, 10.1016/j.ophtha.2013.12.035 · DOI
- Bowman, 2012, ASCEND: design and baseline characteristics of a large randomised trial in diabetes, Diabetes, 61, A556
- Azadbakht, 2007, Better dietary adherence and weight maintenance achieved by a long-term moderate fat diet, British Journal of Nutrition, 97, 399, 10.1017/S0007114507328602 · DOI
- Baldassarre, 2006, Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention, Annals of Medicine, 38, 367, 10.1080/07853890600852880 · DOI
- Berson, 2004, Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment, Archives of Ophthalmology, 122, 1297, 10.1001/archopht.122.9.1297 · DOI · Paper page
- Berson, 2004, Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses, Archives of Ophthalmology, 122, 1306, 10.1001/archopht.122.9.1306 · DOI · Paper page
- Caldwell SH Argo CK Henry TD Lackner C Pramoonjago P Weltman AL Dissociated histological and metabolic effects of omega-e (3000 mg/d) versus placebo with both exercise and diet in a double-blind randomized controlled trial of NASH Journal of Hepatology 2011 S8 · DOI
- Ness, 2004, The long-term effect of dietary advice on the diet of men with angina: the diet and angina randomized trial, Journal of Human Nutrition and Dietetics, 17, 1, 10.1111/j.1365-277X.2004.00506.x · DOI
- Burr, 1991, Fatty fish and heart disease: a randomized controlled trial, World Review of Nutrition and Dietetics, 66, 306, 10.1159/000419300 · DOI
- Burr, 1989, Fish and the heart [letter], Lancet, ii, 1451
- Burr, 1989, Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART), Lancet, 2, 757, 10.1016/S0140-6736(89)90828-3 · DOI · Paper page
- Burr, 1989, Diet and reinfarction trial (DART): design, recruitment, and compliance, European Heart Journal, 10, 558, 10.1093/oxfordjournals.eurheartj.a059528 · DOI
- Burr, 1992, Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART), European Heart Journal, 13, 166, 10.1093/oxfordjournals.eurheartj.a060141 · DOI
- Burr, 1994, Diet and reinfarction [letter], European Heart Journal, 15, 1152, 10.1093/oxfordjournals.eurheartj.a060645 · DOI
- Fehily, 1991, Factors influencing compliance with dietary advice: the Diet and Reinfarction Trial (DART), Journal of Human Nutrition and Dietetics, 4, 33, 10.1111/j.1365-277X.1991.tb00074.x · DOI
- Fehily, 1989, The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART), Journal of Human Nutrition & Dietetics, 2, 4235, 10.1111/j.1365-277X.1989.tb00026.x · DOI
- Ness, 1999, The long-term effect of advice to eat more fish on blood pressure in men with coronary disease: results from the diet and reinfarction trial, Journal of Human Hypertension, 13, 729, 10.1038/sj.jhh.1000913 · DOI
- Derosa, 2016, Effects of n-3 PUFAs on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance, BioFactors (Oxford, England), 42, 316, 10.1002/biof.1277 · DOI
- Deslypere, 1992, Influence of supplementation with n-3 fatty acids on different coronary risk factors in men: a placebo controlled study, Verhandelingen - Koninklijke Vlaamse Academie voor Geneeskunde van Belgie, 54, 189
- Katan, 1997, Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study, Journal of Lipid Research, 38, 2012, 10.1016/S0022-2275(20)37132-7 · DOI · Paper page
- Harrison, 2000, From pies to pilchards: dietary assistants increase consumption of oil rich fish, Journal of Epidemiology and Community Health, Suppl, 6
- Harrison, 2005, Is there a role for long-chain omega3 or oil-rich fish in the treatment of atrial fibrillation?, Medical Hypotheses, 64, 59, 10.1016/j.mehy.2004.06.016 · DOI
- Harrison, 2003, Using community-based dietary assistants to increase the intake of oil-rich fish among older people, European Journal of Public Health, 13, 105
- Berstad, 2003, Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1, Clinical Science, 105, 13, 10.1042/CS20020349 · DOI
- Ellingsen, 2008, Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men, British Journal of Nutrition, 99, 674-81 (Erratum, 10.1017/S0007114507832521 · DOI
- Ellingsen, 2009, Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: a 3-year intervention study, Nutrition Metabolism & Cardiovascular Diseases, 19, 8, 10.1016/j.numecd.2008.01.006 · DOI
- Furenes, 2008, Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein A in men at high risk of coronary heart disease, Scandinavian Journal of Clinical & Laboratory Investigation, 68, 177, 10.1080/00365510701663350 · DOI
- Hjerkinn, 2006, Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia, European Journal of Cardiovascular Prevention & Rehabilitation, 13, 325
- Hjerkinn, 2005, Influence of long-term intervention with dietary counselling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia, American Journal of Clinical Nutrition, 81, 583, 10.1093/ajcn/81.3.583 · DOI
- Lindman, 2004, The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene, Thrombosis & Haemostasis, 91, 1097, 10.1160/TH03-12-0773 · DOI
- Troseid, 2009, Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men, Metabolism: Clinical & Experimental, 58, 1543, 10.1016/j.metabol.2009.04.031 · DOI · Paper page
- Troseid, 2009, Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia, Diabetes Care, 32, 486, 10.2337/dc08-1710 · DOI
- Berstad, 2003, Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1, Clinical Science, 105, 13, 10.1042/CS20020349 · DOI
- Eid, 2006, Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine, Nutrition & Metabolism, 3, 4, 10.1186/1743-7075-3-4 · DOI
- Eid, 2006, Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine, Nutrition and Metabolism, 3, 1, 10.1186/1743-7075-3-1 · DOI
- Einvik, 2010, The influence of long-term awareness of hyperlipidemia and of 3 years of dietary counseling on depression, anxiety, and quality of life, Journal of Psychosomatic Research, 68, 567, 10.1016/j.jpsychores.2009.11.004 · DOI
- Einvik, 2010, A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk, European Journal of Cardiovascular Prevention & Rehabilitation, 17, 588, 10.1097/HJR.0b013e328339cc70 · DOI
- Ellingsen, 2006, Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking study, European Journal of Clinical Nutrition, 60, 378, 10.1038/sj.ejcn.1602327 · DOI
- Furenes, 2008, Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein A in men at high risk of coronary heart disease, Scandinavian Journal of Clinical and Laboratory Investigation, 68, 177, 10.1080/00365510701663350 · DOI
- Hjerkinn, 2006, Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia, European Journal of Cardiovascular Prevention & Rehabilitation, 13, 325
- Hjerkinn, 2005, Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia, American Journal of Clinical Nutrition, 81, 583, 10.1093/ajcn/81.3.583 · DOI
200 of 461 shown
Cited by
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Self-citationOmega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Self-citationReduction in saturated fat intake for cardiovascular disease
Hooper, L., Martin, N., Jimoh, O. F., Kirk, C., Foster, E., & Abdelhamid, A. S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011737.pub3 · Cited by 330
Self-citationBrown, T. J., Brainard, J., Song, F., Wang, X., Abdelhamid, A., & Hooper, L. (2019) · BMJ · doi:10.1136/bmj.l4697 · Cited by 313
Self-citationOmega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., Summerbell, C. D., Worthington, H. V., Song, F., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub5 · Cited by 295
Self-citation
Metadata
- Authors
- Abdelhamid, A. S., Martin, N., Bridges, C., Brainard, J. S., Wang, X., Brown, T. J., Hanson, S., Jimoh, O. F., Ajabnoor, S. M., Deane, K. H., Song, F., & Hooper, L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-07-18
- Volume
- 11
- Pages
- CD012345-CD012345
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2884781685
- Cited by
- 165
- References
- 75
- FWCI
- 15.52
- Type
- journal article
- Language
- en
- Update notices
- new_version (2018-11-27)
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.